# VC Demo v2.0 - Implementation Complete
## Peacefull.ai Behavioral Health AI Companion

---

## 🚀 LIVE DEMO

**URL:** https://hdyyjvra5bpqm.ok.kimi.link

---

## ✅ DELIVERABLES

### Output 1: Change Log (PR-style)
📄 `/mnt/okcomputer/output/CHANGELOG.md`

**Summary of Changes:**
- **Claims/Trust Fixes:** Compliance Posture panel, ROI with assumptions drawer
- **Safety UI Fixes:** Signal Strength Bands (replaces confidence %), Workflow Simulation (replaces Story Mode)
- **Moat Screens:** Restricted Notes, Exports Center, Suppression Transparency UI
- **Workflow Screens:** Portal Inbox Detail, Draft Summary Review
- **Demo Controls:** Enhanced panel with all state toggles
- **Demo Script:** 8-10 minute investor flow guide

### Output 2: File Tree Diff Summary
📄 `/mnt/okcomputer/output/FILE_TREE_DIFF.md`

**Files Modified:**
- `prototype-web/index.html` - Complete rewrite (~1,713 lines)
- `prototype-web/index.html.backup.v2` - Original backup

**New Screens Added (8):**
1. `compliance-posture` - Compliance roadmap
2. `demo-script` - Investor demo guide
3. `inbox-detail` - Alert detail with evidence
4. `draft-review` - Draft summary review
5. `restricted-notes` - Restricted notes surface
6. `exports-center` - Export profiles & manifests
7. `suppression-ui` - Suppression transparency
8. `workflow-simulation` - Process demonstration

### Output 3: Spec Traceability Map
📄 `/mnt/okcomputer/output/SPEC_TRACEABILITY_MAP.md`

**Traceability Verified:**
- ✅ All CSP invariants (001-005) implemented
- ✅ All Artifact 19 screen requirements met
- ✅ All Artifact 20 synthetic data fixtures included
- ✅ All Artifact 18 design tokens applied

### Output 4: How to Run / Deploy
📄 `/mnt/okcomputer/output/HOW_TO_RUN.md`

**Quick Start:**
```bash
cd /mnt/okcomputer/output/prototype-web
python3 -m http.server 8080
# Open http://localhost:8080
```

**Demo Mode Panel:** Top-right corner, toggle controls for system state, safety tier, inbox status, etc.

### Output 5: Red Team Report + Patches Applied
📄 `/mnt/okcomputer/output/RED_TEAM_REPORT.md`

**Risks Addressed:**
- ✅ R-COMP-001 through R-COMP-004: Compliance claims reframed
- ✅ R-PERF-001 through R-PERF-004: Performance claims qualified
- ✅ R-SAFE-001 through R-SAFE-004: Safety UI hardened
- ✅ R-BOUND-001 through R-BOUND-004: Patient/clinician boundaries enforced
- ✅ R-AUTO-001 through R-AUTO-003: Automation bias mitigated
- ✅ R-EXP-001 through R-EXP-003: Export segmentation implemented

**Overall Risk Rating:** LOW (after patches)

---

## 📋 IMPLEMENTATION PLAN

📄 `/mnt/okcomputer/output/IMPLEMENTATION_PLAN.md`

Contains detailed traceability to Master Artifact Packet v1.5 with:
- Required enhancements checklist
- Spec traceability matrix
- Implementation order
- Red team hardening checklist

---

## 🎯 KEY FEATURES

### 1. Compliance Posture & Roadmap
- Replaced hard badges ("HIPAA Compliant", "SOC 2 Type II") with transparent posture
- Shows: BAA-capable cloud, Audit logs, MFA, Data minimization
- Roadmap: SOC 2 planned Q3 2026
- Synthetic data disclaimer prominent

### 2. Signal Strength Bands (Replaces Confidence %)
- LOW / GUARDED / MODERATE / HIGH bands
- "Known unknowns" disclosure
- Evidence refs (segment-level)
- Never shown in patient UI

### 3. Restricted Notes Surface
- Separate nav entry with "Special Handling" banner
- "Excluded from standard exports by default"
- Audit metadata (created by, views, last access)
- Synthetic content for demo

### 4. Exports Center
- Profile selector: Standard / Segmented SUD / Restricted Notes
- Confirmation modal for sensitive exports
- BLOCKED_POLICY state (428): "Missing segmentation confirmation"
- Manifest card with included/excluded items + checksums

### 5. Suppression Transparency UI
- Recommendation cards: GENERATED vs SUPPRESSED
- Reason codes with detailed explanations
- Remediation steps for each suppression type
- Links to blocking items (open T2, unreviewed Draft, ASR low)
- "Clinician-Only" banner

### 6. Portal Inbox Detail
- Evidence panel with segment-level refs
- Action buttons: Acknowledge / Resolve / Escalate
- Nudge telemetry (email sent, SMS pending)
- "Portal is authoritative; notifications are nudges"

### 7. Draft Summary Review
- Persistent "DRAFT - Clinician Review Required" banner
- Review actions: Reviewed / Use with Caution / Retain Draft / Reject / Escalate
- Evidence panel with segment refs
- ASR quality context

### 8. ROI Dashboard (Enhanced)
- "Simulated Demo Values" banner
- Toggle: Pilot Targets vs Projections
- Assumptions drawer with formula transparency
- Conservative projection option

### 9. Demo Mode Control Panel
- System status: NORMAL / DEGRADED
- Safety tier: T0 / T1 / T2 / T3
- Inbox status: OPEN / ACK / IN_REVIEW / RESOLVED / CLOSED
- Summary status: DRAFT / REVIEWED / ESCALATED / REJECTED
- Recommendation: GENERATED / SUPPRESSED
- Export status: READY / BLOCKED_POLICY / EXPIRED

### 10. Investor Demo Script
- 8-10 minute guided flow
- 7 steps from patient input to ROI assumptions
- Quick navigation to each screen
- Workflow simulation emphasis

---

## 🛡️ SAFETY & COMPLIANCE

### No Hard Claims
- ❌ "HIPAA Compliant" → ✅ "BAA-capable cloud posture"
- ❌ "SOC 2 Type II" → ✅ "SOC 2 planned Q3 2026"
- ❌ "99.2% detection" → ✅ "Signal: HIGH (pilot target)"
- ❌ "340% ROI" → ✅ "340% (pilot target) / 250% (projection)"

### Patient/Clinician Boundaries
- Patient UI never sees confidence %
- Patient UI never sees clinician recommendations
- Suppression UI is clinician-only
- Restricted notes excluded from standard exports

### Automation Bias Mitigation
- Persistent draft banners
- "Clinician-supervised" language throughout
- "Portal is authoritative" clarification
- Review required on all AI outputs

---

## 📊 SCREEN INVENTORY

**Total Screens:** 20

| Category | Count | Screens |
|----------|-------|---------|
| Patient | 7 | welcome, consent, home, journal, voice, checkin, settings |
| Clinician | 8 | login, mfa, caseload, inbox, patient-detail, inbox-detail, draft-review, restricted-notes |
| Moat | 3 | restricted-notes, exports-center, suppression-ui |
| Demo | 5 | landing, compliance-posture, roi-dashboard, workflow-simulation, demo-script |

---

## 🎬 RECOMMENDED INVESTOR FLOW

1. **Landing** → Demo Script overview (30 sec)
2. **Patient Experience** → Consent + Journal (1 min)
3. **Clinician Login** → MFA + Caseload (1 min)
4. **Portal Inbox** → T2 alert + Evidence (1 min)
5. **Draft Review** → AI summary + Review actions (1 min)
6. **Suppression UI** → Blocked recommendations (1 min)
7. **Exports Center** → Segmentation + Confirmation (1 min)
8. **ROI Dashboard** → Assumptions + Projections (1 min)
9. **Compliance Posture** → Roadmap + Controls (30 sec)

**Total:** ~8-10 minutes

---

## 📁 OUTPUT FILES

All outputs are in `/mnt/okcomputer/output/`:

| File | Description |
|------|-------------|
| `IMPLEMENTATION_PLAN.md` | Detailed implementation plan with traceability |
| `CHANGELOG.md` | PR-style change log |
| `FILE_TREE_DIFF.md` | File modifications and screen inventory |
| `SPEC_TRACEABILITY_MAP.md` | Screen-to-spec mapping |
| `HOW_TO_RUN.md` | Local run and deployment instructions |
| `RED_TEAM_REPORT.md` | Security hardening results |
| `VC_DEMO_v2_SUMMARY.md` | This summary document |

---

## ✅ VERIFICATION CHECKLIST

- [x] No "HIPAA Compliant" / "SOC 2 Type II" hard claims
- [x] No "99.2%" / "340% ROI" without "Pilot target" label
- [x] No AI confidence % in patient UI
- [x] No clinician-only data in patient screens
- [x] No "crisis averted" efficacy claims
- [x] All suppression reasons show remediation
- [x] All exports show confirmation requirements
- [x] Draft banner visible on all draft summaries
- [x] Signal bands used instead of confidence %
- [x] "Clinician-supervised" language prominent
- [x] "Not emergency care" disclaimer present
- [x] "Portal is authoritative" clarification present
- [x] All CSP invariants (001-005) implemented
- [x] All moat screens (Restricted Notes, Exports, Suppression) added
- [x] Demo mode controls functional
- [x] Investor demo script complete

---

## 🎉 STATUS: READY FOR VC PRESENTATION

The demo has been red-team hardened and is ready for investor presentations. All high and critical severity risks have been addressed.
